Recurrent Pregnancy Loss (RPL)

Recurrent Pregnancy Loss (RPL) is a challenging condition defined by the repeated loss of pregnancy. Medical guidelines differ slightly on the exact definition, with some organizations defining it as two or more pregnancy losses, while others specify three or more consecutive losses. These losses are typically recognized clinically, meaning they are confirmed by ultrasound or tissue examination, and occur before 20 or 24 weeks of gestation. While the experience of RPL can be distressing, it's important to know that a cause can be identified in about half of all cases. These known causes include genetic or chromosomal issues, anatomical problems with the uterus, certain immune system disorders like Antiphospholipid Syndrome (APS), and some endocrine conditions. In approximately 50% of couples, a specific cause is not identified after a standard evaluation, which is known as unexplained RPL. Understanding the potential causes and risk factors is the first step in diagnosis and management. Even with unexplained RPL, the prognosis for a future successful pregnancy is generally good, especially with supportive care.

Symptoms

Repeated loss of pregnancy
Vaginal bleeding (can range from light spotting to heavy bleeding) during a miscarriage
Abdominal or pelvic cramping/pain during a miscarriage
Passage of tissue from the vagina during a miscarriage
Disappearance of pregnancy symptoms (e.g., nausea, breast tenderness) during a miscarriage
No symptoms (in cases of a 'missed' or 'silent' miscarriage, discovered on ultrasound)

Causes & Risk Factors

Parental structural chromosomal abnormalities (e.g., balanced translocations, inversions) in 2-5% of couples
Embryonic/fetal aneuploidy (random numerical chromosome errors), especially with advanced maternal age
Congenital uterine anomalies (e.g., septate uterus, bicornuate uterus, unicornuate uterus, didelphys uterus), with septate uterus most strongly associated with RPL
Acquired uterine anomalies (e.g., submucosal fibroids, intrauterine adhesions/Asherman's syndrome, large polyps)
Antiphospholipid Syndrome (APS), an autoimmune disorder accounting for 5-20% of RPL cases
Thyroid dysfunction (overt hypothyroidism or hyperthyroidism)
Poorly controlled diabetes mellitus
Hyperprolactinemia
Idiopathic/Unexplained RPL (no specific cause identified in approximately 50% of cases)
Advanced maternal age (>35 years, especially >40 years)
Advanced paternal age (>40 years)
Parental balanced chromosomal translocation or inversion
Congenital uterine anomalies (e.g., septate uterus)
Acquired uterine anomalies (e.g., submucosal fibroids, Asherman's syndrome)
Antiphospholipid Syndrome (APS)
Previous pregnancy losses (risk increases with each successive loss)
Obesity (BMI > 30)
Underweight (BMI < 18.5)
Smoking
Excessive alcohol consumption (>5 units/week)
Excessive caffeine intake (>300 mg/day)
Illicit drug use
Poorly controlled medical conditions (e.g., diabetes, thyroid disease)

Diagnosis

Meeting diagnostic criteria of two or more pregnancy losses (ACOG/ASRM) or three or more consecutive losses (RCOG/ESHRE)
Detailed obstetric history (number, timing, and circumstances of each loss)
Medical history (autoimmune diseases, endocrine disorders, thrombotic events)
Surgical history (uterine surgery)
Family history (RPL, congenital anomalies, thrombotic disorders)
Lifestyle factors assessment (smoking, alcohol, BMI, medications)
General physical examination
Pelvic examination (to assess for structural abnormalities or active bleeding/cervical dilation if currently pregnant)
Parental Karyotyping (blood tests for both partners to detect chromosomal abnormalities)
Antiphospholipid Syndrome (APS) screening (blood tests for Lupus anticoagulant, Anticardiolipin antibodies, Anti-β2 glycoprotein I antibodies, confirmed on a second occasion at least 12 weeks later)
Endocrine evaluation (Thyroid Stimulating Hormone (TSH), potentially thyroid peroxidase (TPO) antibodies, Hemoglobin A1c (HbA1c), Prolactin if clinically indicated)
Uterine cavity assessment (Transvaginal ultrasound, Saline infusion sonohysterography (SIS), Hysterosalpingography (HSG), Hysteroscopy, 3D ultrasound)
Genetic analysis of Products of Conception (POC) tissue from a miscarriage (to identify aneuploidy)

Treatment Options

Genetic counseling for parental chromosomal abnormalities
In Vitro Fertilization (IVF) with Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) for parental chromosomal abnormalities
Surgical correction for uterine anomalies (e.g., hysteroscopic metroplasty for uterine septum, myomectomy for submucosal fibroids, lysis of adhesions for Asherman's syndrome)
Low-dose aspirin plus prophylactic-dose heparin for Antiphospholipid Syndrome (APS), started pre-conception or upon positive pregnancy test and confirmed intrauterine pregnancy respectively
Treatment to normalize endocrine function before conception (e.g., levothyroxine for hypothyroidism, tight glycemic control for diabetes)
Psychological support and care in a dedicated early pregnancy clinic for unexplained RPL
Vaginal progesterone supplementation (e.g., 400 mg twice daily) from positive pregnancy test until 16 weeks of gestation for women with a history of miscarriage and bleeding in the current pregnancy (RCOG and NICE recommendation; ESHRE suggests for ≥3 losses; ACOG states insufficient evidence)
Achieve and maintain a healthy BMI
Stop smoking
Reduce or eliminate alcohol and caffeine intake
Folic acid supplementation
Referral to a specialist in RPL or a Maternal-Fetal Medicine (MFM) specialist
Referral to a Reproductive Endocrinologist (if fertility issues or IVF/PGT are considered)
Referral to a genetic counselor for parental chromosomal abnormalities

Frequently Asked Questions

Why do different doctors use two losses versus three losses to define recurrent pregnancy loss?

Medical guidelines from different organizations have varying definitions for recurrent pregnancy loss. The American College of Obstetricians and Gynecologists (ACOG) and the American Society for Reproductive Medicine (ASRM) define it as two or more pregnancy losses. In contrast, the Royal College of Obstetricians and Gynaecologists (RCOG) and the European Society of Human Reproduction and Embryology (ESHRE) define it as three or more consecutive pregnancy losses. These differences reflect ongoing discussions in the medical community about when to initiate a full investigation.

Did I do something to cause my miscarriages?

It is very common for women to feel guilt after a miscarriage, but it's important to understand that most miscarriages are not caused by anything you did or didn't do. While certain lifestyle factors like smoking, excessive alcohol, or being significantly overweight or underweight can increase risk, many cases of recurrent pregnancy loss are due to factors outside of your control, such as genetic issues or uterine problems. In about half of cases, no specific cause is identified, meaning it was not due to your actions.

Should my male partner be tested for anything?

Yes, your male partner should be included in the evaluation for recurrent pregnancy loss. Parental karyotyping, a blood test to check for chromosomal abnormalities, is recommended for both partners. Additionally, abnormal sperm DNA fragmentation is an emerging area of interest that may be considered in some cases.

What is the chance of having a successful pregnancy next time without any treatment?

The prognosis for a future live birth is generally good, even if no specific cause for recurrent pregnancy loss is found. After three unexplained losses, the chance of a successful subsequent pregnancy is approximately 60-70%. This chance is influenced by maternal age; for example, a woman under 30 with unexplained RPL may have over an 80% chance of a live birth, while for a woman over 40, it might be 40-50%.

Does stress cause recurrent miscarriages?

While the emotional impact of recurrent pregnancy loss can be very stressful, the medical dossier does not identify stress as a direct cause of recurrent miscarriages. Psychological support is recognized as an important part of care for women experiencing RPL, but stress itself is not listed as an established risk factor or cause.

Should I be tested for blood clotting disorders (thrombophilia)?

Screening for Antiphospholipid Syndrome (APS), a specific autoimmune blood clotting disorder, is a standard part of the recurrent pregnancy loss evaluation. However, routine screening for inherited thrombophilias (like Factor V Leiden or Prothrombin gene mutation) is generally not recommended by major medical guidelines (ACOG, RCOG, ESHRE) in the absence of other risk factors, as their link to early recurrent pregnancy loss has not been consistently proven, and treatment does not appear to improve outcomes.

Is there a special diet I should follow to prevent another miscarriage?

The dossier does not recommend a specific 'special diet' to prevent another miscarriage. However, maintaining a healthy lifestyle is important. This includes achieving and maintaining a healthy body mass index (BMI), eating a balanced diet, taking folic acid supplementation (as recommended for any planned pregnancy), and avoiding smoking, excessive alcohol, and excessive caffeine intake.

What is Antiphospholipid Syndrome (APS) and how is it treated?

Antiphospholipid Syndrome (APS) is an autoimmune disorder where your immune system mistakenly produces antibodies that can increase the risk of blood clots and pregnancy complications, including recurrent pregnancy loss. It is diagnosed by specific blood tests (Lupus anticoagulant, anticardiolipin antibodies, anti-β2 glycoprotein I antibodies). If diagnosed, the standard treatment during pregnancy involves a combination of low-dose aspirin (started pre-conception or upon positive pregnancy test) and prophylactic-dose heparin (started upon confirmation of intrauterine pregnancy).

Will I need surgery on my uterus?

If an anatomical problem with your uterus is identified as a cause for recurrent pregnancy loss, surgery may be recommended. For example, a septate uterus (a congenital anomaly) can often be corrected with hysteroscopic metroplasty. Similarly, acquired issues like submucosal fibroids or intrauterine adhesions (Asherman's syndrome) can also be treated surgically. The decision for surgery depends on the specific anomaly found and its association with pregnancy loss.

Should we test the tissue from the miscarriage?

Yes, genetic analysis of tissue from a miscarriage (products of conception, or POC) can be valuable. This testing can identify if aneuploidy (a random numerical chromosome error) was the cause of that specific loss. While this information can be helpful for counseling and understanding, it may not always change the management plan for future pregnancies.

Is IVF with genetic testing (PGT-A) a treatment for recurrent pregnancy loss?

For couples where a parental structural chromosomal abnormality (like a balanced translocation) is identified, In Vitro Fertilization (IVF) with Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) is an option. This allows embryos to be screened for the specific chromosomal issue before implantation. The dossier does not specifically recommend PGT-A (Preimplantation Genetic Testing for Aneuploidy, which screens for general chromosome errors) as a routine treatment for unexplained RPL.

Should I take progesterone in my next pregnancy?

Recommendations regarding progesterone supplementation for recurrent pregnancy loss vary among medical organizations. The Royal College of Obstetricians and Gynaecologists (RCOG) and NICE suggest considering vaginal progesterone for women with a history of miscarriage who experience bleeding in the current pregnancy. The European Society of Human Reproduction and Embryology (ESHRE) suggests it can be considered for women with three or more losses. However, the American College of Obstetricians and Gynecologists (ACOG) states that evidence is insufficient to recommend it routinely.

When is it safe to try to conceive again after a loss?

The provided medical dossier does not specify a universal timeline for when it is safe to try to conceive again after a loss. This is a discussion best had with your healthcare provider, who can offer personalized advice based on your individual circumstances and emotional readiness.

Does my age affect my chances of having another miscarriage?

Yes, advanced maternal age is an established risk factor for recurrent pregnancy loss. The risk of miscarriage increases with age, especially for women over 35 and significantly over 40. This is often due to a higher chance of embryonic chromosomal abnormalities as women get older. Your age also affects the prognosis for a successful future pregnancy.

Are there any immune system treatments that can help?

For recurrent pregnancy loss, the only immune system treatment with established benefit is for Antiphospholipid Syndrome (APS), which involves low-dose aspirin and heparin. Other immunotherapies, such as intravenous immunoglobulin (IVIg), corticosteroids, or TNF-alpha inhibitors, are not recommended outside of clinical trials due to a lack of proven benefit and potential risks.

Should I be on bed rest during my next pregnancy?

The medical dossier does not recommend bed rest as a treatment or preventative measure for recurrent pregnancy loss. There is no evidence to suggest that bed rest improves outcomes for women with a history of RPL.

What is a 'chemical pregnancy' and does it count as a loss?

A 'chemical pregnancy' is a very early pregnancy confirmed by a positive pregnancy test (blood or urine) but not yet visible on ultrasound. For the purpose of diagnosing recurrent pregnancy loss, medical guidelines typically define losses as 'clinically-recognized pregnancies,' meaning they are seen on ultrasound or confirmed by tissue examination. Therefore, a chemical pregnancy, while a real loss, may not always be counted towards the diagnostic criteria for RPL by all organizations.

How will my next pregnancy be monitored differently?

If you have a history of recurrent pregnancy loss, your next pregnancy will likely involve more supportive care and closer monitoring. This often includes care in a dedicated early pregnancy clinic, which has been shown to improve outcomes. Your healthcare team will develop a personalized monitoring plan based on any identified causes and your individual risk factors.

What is the difference between a balanced translocation and other chromosome problems?

A balanced translocation is a type of parental structural chromosomal abnormality where parts of chromosomes have swapped places, but no genetic material is lost or gained. The parent carrying it is usually healthy, but it can lead to unbalanced chromosomes in their offspring, causing miscarriage. Embryonic/fetal aneuploidy, on the other hand, refers to random numerical chromosome errors (like having an extra or missing chromosome) that occur during egg or sperm formation or early embryo development, and these account for many sporadic miscarriages.

Are there support groups or counseling services you recommend?

Psychological support and care are recognized as crucial components of managing recurrent pregnancy loss. While the dossier does not list specific support groups, it emphasizes that supportive care, often provided in dedicated early pregnancy clinics, has been shown to improve outcomes. Discussing your emotional well-being with your healthcare provider can help you find appropriate counseling or support resources.

Should I take baby aspirin during my next pregnancy?

Baby aspirin (low-dose aspirin) is a recommended treatment for women diagnosed with Antiphospholipid Syndrome (APS) to prevent recurrent pregnancy loss, typically started pre-conception or upon a positive pregnancy test. However, it is not recommended for unexplained recurrent pregnancy loss or for inherited thrombophilias in the absence of APS. Always consult your doctor before starting any medication during pregnancy.

Can problems with my partner's sperm cause recurrent miscarriages?

While less commonly identified than other causes, abnormal sperm DNA fragmentation is an emerging area of interest in the context of recurrent pregnancy loss. This refers to damage to the genetic material within sperm, which some research suggests could contribute to pregnancy loss. Your healthcare provider may consider evaluating this factor as part of a comprehensive workup.